Introduction Molecular pathology has reshaped the understanding and management of lung cancer, especially non–small cell lung cancer (NSCLC). Advances in genomic profiling have revealed a spectrum of driver mutations that influence tumor behavior, treatment response, and prognosis. Identifying these biomarkers has become essential in tailoring targ
1790 Reached7 Comments
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes
Black Lesion in Old Female
1974 Reached5 Comments11 Likes
NSCLC Treatment To Control Long-term Tumor Growth
216 Reached1 Comments
Secondary Pseudophakic Malignant Glaucoma
1622 Reached21 Comments12 Likes